83 related articles for article (PubMed ID: 18488338)
1. [Transforming growth factor beta upregulates the expression of invasion and metastasis associated proteins in prostate cancer LNCaP cell lines in vitro].
Zhu GF; Cheng HP; Wu KJ; Zhang LL; Zhu GD; Zhang D; He DL
Zhonghua Nan Ke Xue; 2008 Mar; 14(3):238-41. PubMed ID: 18488338
[TBL] [Abstract][Full Text] [Related]
2. [Expression of "epithelial-mesenchymal transition" associated proteins in prostate cancer cell lines with different metastatic potentials and its significance].
Luo Y; He DL; Ning L
Zhonghua Nan Ke Xue; 2006 Aug; 12(8):696-700. PubMed ID: 16970156
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.
Luo Y; He DL; Ning L; Shen SL; Li L; Li X
Chin Med J (Engl); 2006 May; 119(9):713-8. PubMed ID: 16701010
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of metastasis-associated proteins in prostate cancer cell lines with different metastatic potentials].
Luo Y; He DL; Ning L; Zhu GD; Shen SL
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):230-3. PubMed ID: 16597039
[TBL] [Abstract][Full Text] [Related]
5. [Over-expression of HIF-1alpha induces EMT of human prostate cancer cells].
Luo Y; He DL; Jiang YG; Li MC; Ning L; Shen SL
Zhonghua Nan Ke Xue; 2008 Sep; 14(9):800-4. PubMed ID: 18998463
[TBL] [Abstract][Full Text] [Related]
6. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
7. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of E-cadherin and beta-catenin in LNCaP and ARCaP cell lines and their significance].
Jiang YG; Zhao JH; Luo Y; He DL; Li N; Cui XH; Peng T
Zhonghua Nan Ke Xue; 2009 Oct; 15(10):867-71. PubMed ID: 20112731
[TBL] [Abstract][Full Text] [Related]
9. [Identification of TGF-beta/Smads pathway in human prostate cancer cell lines and its significance].
Wu KJ; Zhu GF; Zhang D; Zeng J; Wang XY; Xue Y; Zhang LL; He DL
Zhonghua Nan Ke Xue; 2009 Oct; 15(10):920-4. PubMed ID: 20112742
[TBL] [Abstract][Full Text] [Related]
10. [Over-expression of Hypoxia-inducible factor 1alpha increases invasive potency of LNCaP cells in vitro].
Luo Y; He DL; Ning L; Shen SL; Li L; Li X
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2285-8. PubMed ID: 17064578
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Smad4 in prostate cancer LNCaP and ARCaP cell lines with different metastatic potentials and its significance].
Wu KJ; Zhang D; Zhu GF; Cheng HP; Zeng J; Zhang LL; Wang XY; He DL
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):41-4. PubMed ID: 19288748
[TBL] [Abstract][Full Text] [Related]
12. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
[TBL] [Abstract][Full Text] [Related]
13. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
Jungert K; Buck A; von Wichert G; Adler G; König A; Buchholz M; Gress TM; Ellenrieder V
Cancer Res; 2007 Feb; 67(4):1563-70. PubMed ID: 17308095
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
[TBL] [Abstract][Full Text] [Related]
16. [Characterization of prostate cancer cell lines and their epithelial-mesenchymal transition in subcutaneous tumors].
Zhao L; Jiang YG; Ma J; Luo Y; Zhao JH
Zhonghua Nan Ke Xue; 2011 Apr; 17(4):314-7. PubMed ID: 21548207
[TBL] [Abstract][Full Text] [Related]
17. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
[TBL] [Abstract][Full Text] [Related]
18. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
[TBL] [Abstract][Full Text] [Related]
19. Vimentin affects the mobility and invasiveness of prostate cancer cells.
Zhao Y; Yan Q; Long X; Chen X; Wang Y
Cell Biochem Funct; 2008; 26(5):571-7. PubMed ID: 18464297
[TBL] [Abstract][Full Text] [Related]
20. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
